Skip to content

The effect of resistance training on nerve conduction velocity mediated by NT-3 in women with type 2 diabetes and peripheral neuropathy: A randomized controlled trial

The effect of resistance training on nerve conduction velocity mediated by NT-3 in women with type 2 diabetes and peripheral neuropathy: A randomized controlled trial - The Effect of Training on Nerve Conduction Velocity indiabetic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057715
Enrollment
32
Registered
2025-05-01
Start date
2024-07-10
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

women diabetic type2

Interventions

Sponsors

Shahrood University Of Technology
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)BMI<40 2)Menopause 3)No skeletal disease 4)History of diabetes at least 5 years 5)Maximum blood pressure 160 /95 mmHg 7)Fasting blood sugar at least 126 9)Lack of metabolic conditions other than type2 diabetes 10)Diabetic peripheral neuropathy diagnosis (diabetic neuropathy diagnosis based on Michigan screening) 11)No diabetic foot ulcers and orthopedic problems. 12)No regular exercise. 13)No medical contraindication to exercise(The necessary criteria for the subjects' physical activity level will be determined using the International Physical Activity Questionnaire (IPAQ)).

Exclusion criteria

Exclusion criteria: 1)Insulin therapy 2)Infectious diseases 3)Having skeletal diseases 4)3 sessions of obsenteeism 5)Metabolic conditions Except type2 diabetes 6)Lack of interest in continuing at any stage of the research

Design outcomes

Primary

MeasureTime frame
neurotrophin-3.(pree test and post test) Nerve Conduction Velocity .(pree test and post test)

Countries

Asia(except Japan)

Contacts

Public ContactNasrin Khani

Shahrood University Of Technology Physical Education and Sport Sciences

adelldonyai@yahoo.com098-2332395900

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026